002940.SZ
昂利康
SZSE · Healthcare · C 制造业 · CN
CNY 25.29
−4.17%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
21.5x
Market Cap
CNY 5.10B
MomentumView details →
1D Return
−4.17%
YTD Return
−19.81%
RSI (14)
54.0
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
21.5x
Market Cap
CNY 5.10B
RSI (14)
54.0
MomentumView details →
1D Return
−4.17%
YTD Return
−19.81%
Similar companies
Latest newsMore news →
Anglikang announced its 2026 first-half results: net profit attributable to shareholders was 54.9264 million yuan, down 16.68% year-on-year.12d agoAnglikang and its subsidiary HaiXi Pharmaceutical's three drugs are provisionally selected in the 12th national centralized drug procurement, with the procurement period lasting until December 31, 2029.34d ago